Long-Term Observation of Improvement in Liver Fibrosis Index by A Glucagon-Like Peptide-1 Receptor Agonist in A Patient with Type 2 Diabetes: A Case Report
| Autor: | Akinori Tokito, Nobuyuki Koriyama, Yoshihiko Nishio |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
medicine.diagnostic_test business.industry Liraglutide Type 2 Diabetes Mellitus General Medicine Type 2 diabetes medicine.disease digestive system Gastroenterology digestive system diseases Liver biopsy Internal medicine Nonalcoholic fatty liver disease medicine Blood test business Exenatide Glucagon-like peptide 1 receptor medicine.drug |
| Zdroj: | Archives of Clinical and Medical Case Reports. |
| ISSN: | 2575-9655 |
| Popis: | We describe a 51-year-old man with type 2 diabetes and hepatic dysfunction with suspected nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH). No liver biopsy was performed. His blood test showed a decrease in platelet count (PLT) of 6.3 × 104/μL. Serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were increased, and the AST/ALT ratio (AAR) exceeded 1. FIB4 index, an index of liver fibrosis, was remarkably high at 7.65. On abdominal computed tomography (CT), hepatic parenchyma was visualized as a low absorption area (CT value: 36 HU, L/S ratio |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|